ORAL01.04: Phase II Trial of Atezolizumab for Patients with PD-L1-Selected Advanced NSCLC (BIRCH): Updated Efficacy and Exploratory Biomarker Results: Topic: Medical Oncology.
Details
Serval ID
serval:BIB_10824FA7CB0E
Type
Proceedings: the proceedings of a conference.
Collection
Publications
Institution
Title
ORAL01.04: Phase II Trial of Atezolizumab for Patients with PD-L1-Selected Advanced NSCLC (BIRCH): Updated Efficacy and Exploratory Biomarker Results: Topic: Medical Oncology.
ISSN
1556-1380 (Electronic)
ISSN-L
1556-0864
Issued date
11/2016
Editor
Peters Solange
Volume
11
Number
11S
Language
english
Notes
Publication types: Journal Article
Publication Status: ppublish
Publication Status: ppublish
Pubmed
Create date
21/12/2016 15:53
Last modification date
20/08/2019 13:37
Usage data
